|
Preliminary program
| |
Sunday, September 12th , 2010 |
From 16:30 |
Registration w. Apéro |
|
18:00-19:30 |
Dinner |
|
19:30-19:45 |
Official Opening of the ETW, Announcements |
Sabine Geisse |
19:45-20:45 |
1st Keynote Lecture:
Transposon-based vector systems for robust stable gene transfer and expression in vertebrate cells |
Dr. Zolt án Ivics,
Max Delbrück Center for Molecular Medicine, Berlin, Germany |
21:00 |
Cash Bar |
|
| |
Monday, September 13th, Morning Session |
From 7:30 |
Breakfast |
|
9:00-10:00 |
2 nd Keynote Lecture:
Novartis response to H1N1v - Production and preparation of a cell culture derived adjuvanted flu vaccine |
Dr. Ulrich Valley,
Head Technology Development,
Novartis Vaccines & Diagnostics,
Marburg, Germany |
10:00 |
1 st Session:
|
|
10:00-10:30
|
AGE1.HN - A human designer cell line provides a versatile production platform |
Thomas Rose, ProBioGen AG, Berlin, Germany |
10:30-11:00
|
CAP-T cell expression system: a novel rapid and versatile human cell expression system for fast and high yield transient protein expression |
Jens Wölfel, Cevec Pharmaceuticals GmbH , Köln, Germany |
11:00-11:30 |
Coffee Break |
|
11:30-12:00
|
Improving animal cells process development with fluorescence-based methods
|
Ana P Teixeira, IBET / ITQB-UNL, Oeiras, Portugal |
12:00-12:30
|
Recombinant protein modifications and the influences of bioprocessing operations |
Nigel Jenkins,
Nat’l Inst. Bioprocessing Research & Training, Belfield, Dublin, Ireland |
12:30-13:45 |
Lunch |
|
|
Monday, September 13th, Afternoon Session |
13:45 |
3rd Keynote Lecture:
Retroviral platforms for transient and permanent modification of stem cells
|
Prof. Christopher Baum,
Hannover Medical School, Experimental Hematology, D-30625 Hannover, Germany |
14:45 |
2nd Session:
|
|
14:45-15:15
|
Sequence specific applications in cell line engineering to improve product quality and to increase its titer |
Oliver Kraemer, University of Bielefeld, Germany |
15:15-15:45
|
Recombinant FVIII purification antibody for manufacturing of N8 |
J.J. Hansen, Novo Nordisk A/S, Novo Nordisk Park, Maaloev, Denmark |
15:45-16:1 5 |
Coffee Break |
|
16:15-16:45
|
Fast, efficient and high quality cell line generation as key to success in development of biopharmaceuticals |
Burkhard Wilms, Novartis Pharma AG, Switzerland |
16:45-17:1 5
|
Identification of critical parameters influencing the success of transient protein production in CHO cells |
Bernd Voedisch, Novartis Institutes for BioMedical Research, Basel, Switzerland |
17:15-19:30 |
Poster Viewing with Apéro |
|
19:30 |
Dinner |
|
21:00 |
Cash Bar |
|
|
Tuesday, September 14th, Morning Session |
From 7:00 |
Breakfast |
9:00-10:00 |
4th Keynote Lecture:
Synthetic biology in mammalian cells and materials science |
Prof. Wilfried Weber,
bioss Centre for Biological Signalling Studies, Albert-Ludwigs Universität Freiburg, Germany |
10:00 |
3rd Session:
|
|
10:00-10:30 |
The evolution of single use bioreactors: design, application and validation
|
Roman Rodriguez, ATMI Life Sciences, Hoegaarden, Belgium |
10:30-11:00 |
Investigation of orbitally shaken bioreactor hydrodynamics
|
Martino Reclari, Lab.Cellular Biotechnology, EPFL SV-IBI-LBTC, Lausanne, Switzerland |
11:00-11:30 |
Coffee Break
|
|
11:30-12:00 |
Predictive metabolic flux analysis as a powerful tool to assist bioprocess optimization |
Nuno Carinhas, IBET/ITQB/FCT, Universidade Nova de Lisboa, Portugal |
12:00-12:30 |
Biomolecule production using PEI-mediated transient transfection |
Patrick Erbacher, Polyplus-transfection S.A., Illkirch, France |
12:30-12:45 |
Wrap-up and Closing of the Workshop |
|
12:45 |
Lunch |
|
14:00 |
Departure; Optional: Tour of the Cloister |
|
powered by:
Copyright 2009-2010 by ETW2010 (Holger Heine)
|
|